Your browser doesn't support javascript.
loading
Longitudinal Assessment of Pain Management Among the Employed Japanese Population with Knee Osteoarthritis.
Ueda, Kaname; Takura, Tomoyuki; Fujikoshi, Shinji; Meyers, Juliana; Nagar, Saurabh P; Enomoto, Hiroyuki.
Afiliación
  • Ueda K; Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan.
  • Takura T; Department of Healthcare Economics and Health Policy, University of Tokyo, Tokyo, Japan.
  • Fujikoshi S; Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan.
  • Meyers J; RTI Health Solutions, Research Triangle Park, NC, USA.
  • Nagar SP; RTI Health Solutions, Research Triangle Park, NC, USA.
  • Enomoto H; Medicines Development Unit Japan, Eli Lilly Japan K.K., Kobe, Japan.
Clin Interv Aging ; 15: 1003-1012, 2020.
Article en En | MEDLINE | ID: mdl-32617001
ABSTRACT

PURPOSE:

To assess comorbidity burden and pain-management patterns among working-aged patients with knee osteoarthritis only (KOA/O) and patients with knee osteoarthritis plus osteoarthritis at another site (KOA/+) in Japan. PATIENTS AND

METHODS:

Retrospective claims data analysis was conducted using the Japan Medical Data Center database. Working-aged adults (aged 40 to 71 years) with 5 years of follow-up and diagnosed with knee osteoarthritis (KOA) between January 1, 2011, and December 31, 2012, were evaluated. The first claim with a KOA diagnosis defined the index date. Patients were divided into two mutually exclusive cohorts KOA/O and KOA/+. Longitudinal pain-management patterns during each year of follow-up were analyzed.

RESULTS:

A total of 2542 patients met study criteria 1575 KOA/O and 967 KOA/+. Mean age and number of comorbidities were higher among the KOA/+ versus KOA/O cohort. Pharmaceutical treatment was received by 91.5% of patients in the KOA/+ compared with 85.1% of patients in the KOA/O cohort during the first year of follow-up. The most common pharmacological treatment received during the first year of follow-up was either topical or oral nonsteroidal anti-inflammatory drugs for both cohorts. During each year of follow-up, the KOA/+ cohort had greater proportion of patients with at least one health-care encounter (ie, hospital admissions, outpatient and pharmacy visits) and higher direct medical costs compared with the KOA/O cohort.

CONCLUSION:

This study demonstrates that a greater proportion of the working population with KOA/+ received pain-related treatment compared with patients with KOA/O. Further studies are necessary to evaluate appropriate pain management for both KOA only and KOA with other sites.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Osteoartritis de la Rodilla / Manejo del Dolor Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Interv Aging Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor / Osteoartritis de la Rodilla / Manejo del Dolor Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Interv Aging Asunto de la revista: GERIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Japón